ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
¿©ÇàÀÚŬ¸®´Ð
-
[SCI]
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward
Nham E, Song JY, Kim WJ.
/ COVID-19 Vaccination in Korea: Past, Present, and the Way Forward
/ 2022;37:e351
/ 202212
-
[SCI]
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
Jeong HW, Noh JY, Song JY, Choi YK.
/ Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
/ 202211
-
[SCI]
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.
Heo JY, Song JY.
/ COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.
/ 2022;13:975363
/ 202210
-
[SCI]
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, phase 1/2 trial
Song JY, Choi WS, Cheong HJ.
/ Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, phase 1/2 trial
/ 2022;51:101569
/ 202209
-
[SCI]
The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses.
Jung S, Noh JY, Song JY, Shin EC.
/ The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses.
/ 202208